Literature DB >> 8281158

Genetic heterogeneity for Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis.

M R Passos-Bueno1, J R Oliveira, E Bakker, R D Anderson, S K Marie, M Vainzof, S Roberds, K P Campbell, M Zatz.   

Abstract

Duchenne-like muscular dystrophy (DLMD) is an autosomal recessive (AR) muscular dystrophy which presents a clinical course indistinguishable from the Xp21 Duchenne muscular dystrophy or DMD. Recently, Othmane et al., based on a linkage study with 13q12 markers in 3 highly inbred DLMD families from Tunisia, suggested that the gene for this myopathy lies in the pericentromeric region of chromosome 13q. It is unknown if there is genetic heterogeneity causing the DLMD phenotype. Therefore, the aim of the present report is to describe the results of linkage analysis in 4 Brazilian DLMD families with 13q12 markers (D13S115 and D13S120), which were also tested for 50DAG. It was possible to exclude the 13q gene at theta = 0.10 as responsible for the DLMD phenotype in our families using both 13q12 markers, if the lod scores of each family were added up. Interestingly, 3 families were deficient for 50 DAG while one showed a positive pattern for this glycoprotein. Therefore, these results suggest: a) the DLMD phenotype is caused by more than one recessive gene; b) a gene, not located at 13q, causes deficiency of 50 DAG as a primary or secondary defect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8281158     DOI: 10.1093/hmg/2.11.1945

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

1.  Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families.

Authors:  M R Passos-Bueno; E S Moreira; S K Marie; R Bashir; L Vasquez; D R Love; M Vainzof; P Iughetti; J R Oliveira; E Bakker; T Strachan; K Bushby; M Zatz
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

2.  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D).

Authors:  A Carrié; F Piccolo; F Leturcq; C de Toma; K Azibi; C Beldjord; J M Vallat; L Merlini; T Voit; C Sewry; J A Urtizberea; N Romero; F M Tomé; M Fardeau; Y Sunada; K P Campbell; J C Kaplan; M Jeanpierre
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 3.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

Review 4.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient in adhalin.

Authors:  I Higuchi; H Yamada; H Fukunaga; H Iwaki; R Okubo; M Nakagawa; M Osame; S L Roberds; T Shimizu; K P Campbell
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  Human adhalin is alternatively spliced and the gene is located on chromosome 17q21.

Authors:  E M McNally; M Yoshida; Y Mizuno; E Ozawa; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

7.  Sarcoglycan complex is selectively lost in dystrophic hamster muscle.

Authors:  Y Mizuno; S Noguchi; H Yamamoto; M Yoshida; I Nonaka; S Hirai; E Ozawa
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency.

Authors:  H Kawai; M Akaike; T Endo; K Adachi; T Inui; T Mitsui; S Kashiwagi; T Fujiwara; S Okuno; S Shin
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Dysferlin protein analysis in limb-girdle muscular dystrophies.

Authors:  M Vainzof; L V Anderson; E M McNally; D B Davis; G Faulkner; G Valle; E S Moreira; R C Pavanello; M R Passos-Bueno; M Zatz
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

Review 10.  Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era.

Authors:  Eijiro Ozawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.